<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000405813">
  <TermName>SGN-40</TermName>
  <TermDefinition>
    <DefinitionText>A monoclonal antibody that binds to cells that have the CD40 antigen on their surface, including cells from multiple myeloma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. SGN-40 is being studied in the treatment of cancer. It is a type of monoclonal antibody.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>SGN-40</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Anticuerpo monoclonal que se une a las células que tienen el antígeno CD40 sobre sus superficies, como las células del mieloma múltiple, del linfoma no Hodgkin y de la leucemia linfocítica crónica. El SGN-40 está en estudio para el tratamiento de cáncer. Es un tipo de anticuerpo monoclonal.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-11-05</DateFirstPublished>
  <DateLastModified>2007-09-21</DateLastModified>
</GlossaryTerm>
